Metrics
- Impact factor
- 4.7+0.4 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 0.702Q2 SCImago
- h-index
- 44
- CAS tier
- Tier 3 Chinese Academy of Sciences
- Citations per paper
- 5.81 last 2 years
- Articles per year
- 33
- Self-citation
- 5.6%
- Fee (APC), est.
- $3,116 estimated, check the journal
About this journal
- ISSN
- 0898-2104 (print) · 1532-2394 (online)
- Publisher
- Taylor & Francis
- Country
- United States · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 4.1% gold OA
- Founded
- 1988
- Frequency
- Quarterly
- Original research
- 79.2%
- Subject areas
- Pharmacology, Toxicology and Pharmaceutics
- Categories
- Biology, Biochemistry & Molecular Biology
- Common topics
- Materials Science, Biology, Chemistry, Biochemistry, Nanotechnology
Similar journals
- Q1WoS
Nature Reviews Drug Discovery
Impact factor 91.2h-index 289SJR 32.58 - Q1WoS
Advanced Drug Delivery Reviews
Impact factor 21h-index 278SJR 4.01 - Q1WoS
Journal of Medicinal Chemistry
Impact factor 7.3h-index 240SJR 1.73 - Q1WoS
Pain
Impact factor 5.8h-index 238SJR 2.13 - Q1WoS
Journal of Controlled Release
Impact factor 12.4h-index 237SJR 2.54 - Q1WoS
Antimicrobial Agents and Chemotherapy
Impact factor 4.2h-index 232SJR 1.47
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals